The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
Abstract
Escherichia coli sequence type 131 (ST131) is a worldwide pandemic clone, causing predominantly community-onset antimicrobial-resistant infection. Its pandemic spread was identified in 2008 by utilizing multilocus sequence typing (MLST) of CTX-M-15 extended-spectrum β-lactamase-producing E. coli from three continents. Subsequent research has confirmed the worldwide prevalence of ST131 harbouring a broad range of virulence and resistance genes on a transferable plasmid. A high prevalence of the clone (∼30%-60%) has been identified amongst fluoroquinolone-resistant E. coli. In addition, it potentially harbours a variety of β-lactamase genes; most often, these include CTX-M family β-lactamases, and, less frequently, TEM, SHV and CMY β-lactamases. Our knowledge of ST131's geographical distribution is incomplete. A broad distribution has been demonstrated amongst antimicrobial-resistant E. coli from human infection in Europe (particularly the UK), North America, Canada, Japan and Korea. High rates are suggested from limited data in Asia, the Middle East and Africa. The clone has also been detected in companion animals, non-companion animals and foods. The clinical spectrum of disease described is similar to that for other E. coli, with urinary tract infection predominant. This can range from cystitis to life-threatening sepsis. Infection occurs in humans of all ages. Therapy must be tailored to the antimicrobial resistance phenotype of the infecting isolate and the site of infection. Phenotypic detection of the ST131 clone is not possible and DNA-based techniques, including MLST and PCR, are described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Rapid and Simple Determination of the Escherichia coli Phylogenetic Group
Clermont, O., Bonacorsi, S., & Bingen, E. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.10.4555-4558.2000 · Cited by 2,645
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
(2015) · Elsevier eBooks · doi:10.1016/c2012-1-00075-6 · Cited by 2,577
Sex and virulence in Escherichia coli: an evolutionary perspective
Wirth, T., Falush, D., Lan, R., Colles, F., Mensa, P., Wieler, L. H., Karch, H., Reeves, P. R., Maiden, M. C. J., Ochman, H., et al. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05172.x · Cited by 2,025
Control of Communicable Diseases Manual
(2015) · American Public Health Association eBooks · doi:10.2105/ccdm.2745 · Cited by 1,599
Virulence factors in Escherichia coli urinary tract infection
Johnson, J. R. (1991) · Clinical Microbiology Reviews · doi:10.1128/cmr.4.1.80 · Cited by 1,290
The CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,147
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Hye Park, C., Bush, K., & Hooper, D. C. (2006) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,013
The worldwide emergence of plasmid-mediated quinolone resistance
Robicsek, A., Jacoby, G. A., & Hooper, D. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70599-0 · Cited by 966
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Nicolas-Chanoine, M.-H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M. P., Canica, M. M., Park, Y.-J., Lavigne, J.-P., Pitout, J., & Johnson, J. R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm464 · Cited by 821
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Pitout, J. D. D., Nordmann, P., Laupland, K. B., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki166 · Cited by 790
Coque, T. M., Novais, Â., Carattoli, A., Poirel, L., Pitout, J., Peixe, L., Baquero, F., Cantón, R., & Nordmann, P. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1402.070350 · Cited by 702
Gupta, K. (1999) · JAMA · doi:10.1001/jama.281.8.736 · Cited by 609
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/420816 · Cited by 571
Self-citationManges, A. R., Johnson, J. R., Foxman, B., O'Bryan, T. T., Fullerton, K. E., & Riley, L. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011265 · Cited by 531
Johnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A., & Castanheira, M. (2010) · Clinical Infectious Diseases · doi:10.1086/653932 · Cited by 510
Woodford, N., Ward, M. E., Kaufmann, M. E., Turton, J., Fagan, E. J., James, D., Johnson, A. P., Pike, R., Warner, M., Cheasty, T., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh424 · Cited by 472
Boudeau, J., Glasser, A.-L., Masseret, E., Joly, B., & Darfeuille-Michaud, A. (1999) · Infection and Immunity · doi:10.1128/iai.67.9.4499-4509.1999 · Cited by 448
Boyd, D. A., Tyler, S., Christianson, S., McGeer, A., Muller, M. P., Willey, B. M., Bryce, E., Gardam, M., Nordmann, P., & Mulvey, M. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3758-3764.2004 · Cited by 389
Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
Rodríguez-Baño, J., Alcalá, J. C., Cisneros, J. M., Grill, F., Oliver, A., Horcajada, J. P., Tórtola, T., Mirelis, B., Navarro, G., Cuenca, M., et al. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.17.1897 · Cited by 379
Pitout, J. D. D. (2010) · Drugs · doi:10.2165/11533040-000000000-00000 · Cited by 376
A new plasmidic cefotaximase in a clinical isolate of Escherichia coli
Bauernfeind, A., Schweighart, S., & Grimm, H. (1990) · Infection · doi:10.1007/bf01647010 · Cited by 363
Karim, A., Poirel, L., Nagarajan, S., & Nordmann, P. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10762.x · Cited by 359
Kim, Y.-K., Pai, H., Lee, H.-J., Park, S.-E., Choi, E.-H., Kim, J., Kim, J.-H., & Kim, E.-C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1481-1491.2002 · Cited by 357
Clermont, O., Dhanji, H., Upton, M., Gibreel, T., Fox, A., Boyd, D., Mulvey, M. R., Nordmann, P., Ruppe, E., Sarthou, J. L., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp194 · Cited by 357
Paterson, D. L. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.00107.x · Cited by 310
Self-citationDetection of β-lactamase-mediated resistance
Livermore, D. M., & Brown, D. F. J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.59 · Cited by 307
Food Reservoir for Escherichia coli Causing Urinary Tract Infections
Vincent, C., Boerlin, P., Daignault, D., Dozois, C. M., Dutil, L., Galanakis, C., Reid-Smith, R. J., Tellier, P.-P., Tellis, P. A., Ziebell, K., et al. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1601.091118 · Cited by 298
Woodford, N., Carattoli, A., Karisik, E., Underwood, A., Ellington, M. J., & Livermore, D. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00688-09 · Cited by 283
Tumbarello, M., Spanu, T., Sanguinetti, M., Citton, R., Montuori, E., Leone, F., Fadda, G., & Cauda, R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.498-504.2006 · Cited by 283
Ewers, C., Grobbel, M., Stamm, I., Kopp, P. A., Diehl, I., Semmler, T., Fruth, A., Beutlich, J., Guerra, B., Wieler, L. H., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq004 · Cited by 279
Clermont, O., Lavollay, M., Vimont, S., Deschamps, C., Forestier, C., Branger, C., Denamur, E., & Arlet, G. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn084 · Cited by 274
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4574-4581.2004 · Cited by 267
Poirel, L., Kämpfer, P., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.4038-4040.2002 · Cited by 266
Johnson, J. R., Menard, M., Johnston, B., Kuskowski, M. A., Nichol, K., & Zhanel, G. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00297-09 · Cited by 265
Hawser, S. P., Bouchillon, S. K., Hoban, D. J., Badal, R. E., Hsueh, P.-R., & Paterson, D. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00426-09 · Cited by 224
Self-citationCortés, P., Blanc, V., Mora, A., Dahbi, G., Blanco, J. E., Blanco, M., López, C., Andreu, A., Navarro, F., Alonso, M. P., et al. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.02421-09 · Cited by 218
Du, B., Long, Y., Liu, H., Chen, D., Liu, D., Xu, Y., & Xie, X. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1521-1 · Cited by 207
Rooney, P. J., O'Leary, M. C., Loughrey, A. C., McCalmont, M., Smyth, B., Donaghy, P., Badri, M., Woodford, N., Karisik, E., & Livermore, D. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp220 · Cited by 198
Zanetti, G., Bally, F., Greub, G., Garbino, J., Kinge, T., Lew, D., Romand, J.-A., Bille, J., Aymon, D., Stratchounski, L., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3442-3447.2003 · Cited by 190
Suzuki, S., Shibata, N., Yamane, K., Wachino, J.-I., Ito, K., & Arakawa, Y. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn463 · Cited by 178
Lau, S. H., Reddy, S., Cheesbrough, J., Bolton, F. J., Willshaw, G., Cheasty, T., Fox, A. J., & Upton, M. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02065-07 · Cited by 174
Oteo, J., Diestra, K., Juan, C., Bautista, V., Novais, Â., Pérez-Vázquez, M., Moyá, B., Miró, E., Coque, T. M., Oliver, A., et al. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.03.006 · Cited by 173
Cagnacci, S., Gualco, L., Debbia, E., Schito, G. C., & Marchese, A. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00640-08 · Cited by 166
Morosini, M.-I., García-Castillo, M., Coque, T. M., Valverde, A., Novais, A., Loza, E., Baquero, F., & Cantón, R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00155-06 · Cited by 166
Lau, S. H., Kaufmann, M. E., Livermore, D. M., Woodford, N., Willshaw, G. A., Cheasty, T., Stamper, K., Reddy, S., Cheesbrough, J., Bolton, F. J., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn380 · Cited by 163
Garau, J. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01852.x · Cited by 145
Pitout, J. D. D., Gregson, D. B., Campbell, L., & Laupland, K. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00247-09 · Cited by 145
Leflon‐Guibout, V., Blanco, J., Amaqdouf, K., Mora, A., Guize, L., & Nicolas-Chanoine, M.-H. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00734-08 · Cited by 144
Clermont, O., Johnson, J. R., Menard, M. L., & Denamur, É. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.08.007 · Cited by 130
Sidjabat, H. E., Paterson, D. L., Adams‐Haduch, J. M., Ewan, L., Pasculle, A. W., Muto, C. A., Tian, G., & Doi, Y. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00533-09 · Cited by 127
Self-citationBlanco, M., Alonso, M. P., Nicolas-Chanoine, M.-H., Dahbi, G., Mora, A., Blanco, J. E., López, C., Cortés, P., Llagostera, M., Leflon‐Guibout, V., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp122 · Cited by 126
Johnson, J. R., Miller, S. A., Johnston, B., Clabots, C., & DebRoy, C. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01581-09 · Cited by 119
Arpin, C., Quentin, C., Grobost, F., Cambau, E., Robert, J., Dubois, V., Coulange, L., & André, C. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp108 · Cited by 118
Emergence of imipenem resistance in clinical Escherichia coli during therapy
Oteo, J., Delgado‐Iribarren, A., Vega, D., Bautista, V., Rodríguez, M. C., Velasco, M., Saavedra, J. M., Pérez-Vázquez, M. D., García-Cobos, S., Martínez-Martínez, L., et al. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.06.012 · Cited by 117
Endemic and Epidemic Lineages ofEscherichia colithat Cause Urinary Tract Infections
Manges, A. R., Tabor, H., Tellis, P. A., Vincent, C., & Tellier, P. (2008) · Emerging infectious diseases · doi:10.3201/eid1410.080102 · Cited by 115
Olson, A. B., Silverman, M., Boyd, D. A., McGeer, A., Willey, B. M., Pong-Porter, V., Daneman, N., & Mulvey, M. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2112-2115.2005 · Cited by 115
Peirano, G., Richardson, D. C., Nigrin, J., McGeer, A., Loo, V. G., Toye, B., Alfa, M. J., Pienaar, C., Kibsey, P., & Pitout, J. D. D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01338-09 · Cited by 113
Pomba, C., da Fonseca, J. D., Baptista, B., Correia, J. D., & Martı́nez-Martı́nez, L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00896-08 · Cited by 107
Mora, A., Herrera, A., Mamani, R. C., López, C., Alonso, M. P., Blanco, J. E., Blanco, M., Dahbi, G., Garcı́a-Garrote, F., Pita, J., et al. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.01112-10 · Cited by 103
Oteo, J., Orden, B., Bautista, V., Cuevas, Ó., Arroyo, M., Martínez-Ruiz, R., Pérez-Vázquez, M. D., Alcaraz, M., García-Cobos, S., & Campos, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp288 · Cited by 99
Martínez-Medina, M., Mora, A., Blanco, M., López, C., Alonso, M. P., Bonacorsi, S., Nicolas-Chanoine, M.-H., Darfeuille–Michaud, A., Garcia-Gil, L. J., & Blanco, J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01484-09 · Cited by 99
Yumuk, Z., Afacan, G., Nicolas-Chanoine, M.-H., Sotto, A., & Lavigne, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn181 · Cited by 86
Naseer, U., Haldorsen, B. C., Tofteland, S., Hegstad, K., Scheutz, F., Simonsen, G. S., Sundsfjord, A., & THE NORWEGIAN ESBL STUDY GROUP (2009) · Apmis · doi:10.1111/j.1600-0463.2009.02465.x · Cited by 84
Naseer, U., Haldorsen, B. C., Simonsen, G. S., et al. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02861.x · Cited by 79
Gavin, P. J., Suseno, M. T., Thomson, R. B., Gaydos, J. M., Pierson, C. L., Halstead, D. C., Aslanzadeh, J., Brecher, S. M., Rotstein, C., Brossette, S. E., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00381-05 · Cited by 75
Literacka, E., Bedenić, B., Baraniak, A., Fiett, J., Tonkić, M., Jajić-Benčić, I., & Gniadkowski, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01431-08 · Cited by 73
Vigil, K. J., Johnson, J. R., Johnston, B., Kontoyiannis, D. P., Mulanovich, V. E., RAAD, I. I., DuPont, H. L., & Adachi, J. A. (2009) · Clinical Infectious Diseases · doi:10.1086/649866 · Cited by 73
A Change in the Epidemiology of Infections Due to Extended-Spectrum -Lactamase--Producing Organisms
Rodríguez‐Baño, J., & Paterson, D. L. (2006) · Clinical Infectious Diseases · doi:10.1086/500945 · Cited by 72
Self-citationBert, F., Johnson, J. R., Ouattara, B., Leflon-Guibout, V., Johnston, B., Marcon, E., Valla, D., Moreau, R., & Nicolas-Chanoine, M.-H. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00516-10 · Cited by 71
Ender, P. T., Gajanana, D., Johnston, B., Clabots, C., Tamarkin, F. J., & Johnson, J. R. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01361-09 · Cited by 71
Platell, J. L., Cobbold, R. N., Johnson, J. R., & Trott, D. J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq236 · Cited by 70
Pitout, J. D. D., Campbell, L., Church, D. L., Gregson, D. B., & Laupland, K. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00061-09 · Cited by 70
Orthodox and unorthodox clavulanate combinations against extended-spectrum β-lactamase producers
Livermore, D. M., Hope, R., Mushtaq, S., & Warner, M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01858.x · Cited by 70
Lee, M., Choi, H. J., Choi, J. Y., Song, M., Song, Y., Kim, S., Chang, H., Jung, S.-I., Ys, K., Ki, H. K., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.11.004 · Cited by 69
Peirano, G., Costello, M., & Pitout, J. D. D. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.02.016 · Cited by 68
Jones, G., Warren, R. E., Skidmore, S., Davies, V. A., Gibreel, T. M., & Upton, M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn406 · Cited by 65
Pitout, J. D. D., Campbell, L., Church, D. L., Wang, P. W., Guttman, D. S., & Gregson, D. B. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02265-08 · Cited by 58
Freeman, J. T., McBride, S., Heffernan, H., Bathgate, T., Pope, C., & Ellis-Pegler, R. B. (2008) · Clinical Infectious Diseases · doi:10.1086/590941 · Cited by 57
Peirano, G., Greune, C. H. J. V., & Pitout, J. D. D. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.11.011 · Cited by 57
Johnson, J. R., Stell, A. L., O’Bryan, T. T., Kuskowski, M. A., Nowicki, B. J., Johnson, C. E., Maslow, J. N., Kaul, A., Kavle, J. A., & Prats, G. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.1913-1923.2002 · Cited by 56
Dhanji, H., Doumith, M., Clermont, O., Denamur, É., Hope, R., Livermore, D. M., & Woodford, N. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.06.007 · Cited by 55
Oteo, J., Diestra, K., Juan, C., Bautista, V., Novais, Â., Pérez-Vázquez, M. D., Moyá, B., Miró, E., Coque, T. M., Oliver, A., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.07.001 · Cited by 51
Bassetti, M., Righi, E., Fasce, R., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm180 · Cited by 47
Johnson, J. R., Anderson, J. T., Clabots, C., Johnston, B., & Cooperstock, M. S. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181c89bd7 · Cited by 44
Oteo, J., Cercenado, E., Cuevas, Ó., Bautista, V., Delgado‐Iribarren, A., Orden, B., Pérez-Vázquez, M. D., García-Cobos, S., & Campos, J. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.02.008 · Cited by 43
Lau, S., Cheesborough, J., Kaufmann, M. E., Woodford, N., Dodgson, A. R., Dodgson, K., Bolton, E., Fox, A. J., & Upton, M. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02733.x · Cited by 37
Uchida, Y., Mochimaru, T., Morokuma, Y., Kiyosuke, M., Fujise, M., Eto, F., Eriguchi, Y., Nagasaki, Y., Shimono, N., & Kang, D. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.012 · Cited by 30
Prospero, E., a, D., C, N., F, R., Byl, B., & Struelens, M. J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.0902e.x · Cited by 3
Cited by
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627
Self-citationBeceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,070
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Sarowska, J., Futoma-Koloch, B., Jama-Kmiecik, A., Frej-Madrzak, M., Ksiazczyk, M., Bugla-Ploskonska, G., & Choroszy-Krol, I. (2019) · Gut Pathogens · doi:10.1186/s13099-019-0290-0 · Cited by 718
Ewers, C., Bethe, A., Semmler, T., Guenther, S., & Wieler, L. H. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03850.x · Cited by 677
Metadata
- Authors
- Rogers, B. A., Sidjabat, H. E., & Paterson, D. L.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-11-16
- Volume
- 66
- Issue
- 1
- Pages
- 1-14
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2098716491
- Cited by
- 716
- References
- 91
- FWCI
- 26.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.